Kayla Gabbett, PA
Physician Assistant · West Chester, PANPI 1649880584
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $578 and has fallen 81.5% since, to $107 in 2025.
Across 53 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$154
- Novo Nordisk$99
- Biohaven Pharmaceuticals, Inc.$75
- Lilly USA, LLC$74
- Merck$72
- E.r. Squibb & Sons, L.L.C.$69
- plus $409 from 15 others
What the payments were for
- Food & beverage$952100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $154 |
| Novo Nordisk | 6 | $99 |
| Biohaven Pharmaceuticals, Inc. | 4 | $75 |
| Lilly USA, LLC | 5 | $74 |
| Merck | 4 | $72 |
| E.r. Squibb & Sons, L.L.C. | 3 | $69 |
| Boehringer Ingelheim | 3 | $61 |
| Bayer | 2 | $46 |
| Mannkind Corporation | 2 | $44 |
| AstraZeneca | 3 | $43 |
| Philips North America LLC | 2 | $37 |
| Amgen | 2 | $29 |
| Johnson & Johnson | 1 | $20 |
| Biomerieux Inc | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$952 in reported general payments places this provider in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefpodoxime Proxetil | 13 | $510 |
| Pantoprazole Sodium | 14 | $128 |
| Prednisone | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in West Chester
- Erin CrownState College$1.2M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Jeffrey CameronWashington$89K
- Dorissa BrivchikPittsburgh$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.